Compile Data Set for Download or QSAR
Report error Found 21 for UniProtKB: P61956
LigandPNGBDBM103826(SPI-01 | US9791447, Compound SPI-01 | US11041859, ...)
Affinity DataIC50: 1.10E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50: 1.86E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US9791447, Compound SPI-01 | US11041859, ...)
Affinity DataIC50: 1.88E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US9791447, Compound SPI-02 | US11041859, ...)
Affinity DataIC50: 2.08E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103829(SPI-04 | US9791447, Compound SPI-04 | US11041859, ...)
Affinity DataIC50: 2.15E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US9791447, Compound SPI-04 | US11041859, ...)
Affinity DataIC50: 2.32E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103827(SPI-02 | US9791447, Compound SPI-02 | US11041859, ...)
Affinity DataIC50: 2.70E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50: 3.00E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US9791447, Compound SPI-06 | US11041859...)
Affinity DataIC50: 4.32E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103830(SPI-05 | US9791447, Compound SPI-05 | US11041859, ...)
Affinity DataIC50: 4.60E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US9791447, Compound SPI-05 | US11041859, ...)
Affinity DataIC50: 7.50E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM348888(NSC70551 | US9791447, Compound SPI-06 | US11041859...)
Affinity DataIC50: 1.07E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103835(SPI-10 | US9791447, Compound SPI-10 | US11041859, ...)
Affinity DataIC50: 1.11E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103832(SPI-07 | US11041859, Code SPI-07)
Affinity DataIC50: 1.75E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 2(Human)
Johann Wolfgang Goethe University

Curated by ChEMBL
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  1.83E+4nMAssay Description:Binding affinity to human SUMO2 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
LigandPNGBDBM103834(SPI-09 | US9791447, Compound SPI-09 | US11041859, ...)
Affinity DataIC50: 2.66E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103832(SPI-07 | US11041859, Code SPI-07)
Affinity DataIC50: 2.81E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103835(SPI-10 | US9791447, Compound SPI-10 | US11041859, ...)
Affinity DataIC50: 3.64E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

LigandPNGBDBM103833(SPI-08 | US9791447, Compound SPI-08 | US11041859, ...)
Affinity DataIC50: 4.11E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103834(SPI-09 | US9791447, Compound SPI-09 | US11041859, ...)
Affinity DataIC50: 6.00E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetSmall ubiquitin-related modifier 1/2(Human)
City of Hope

US Patent
LigandPNGBDBM103833(SPI-08 | US9791447, Compound SPI-08 | US11041859, ...)
Affinity DataIC50: 6.00E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent